Handbook Generic Development
Master Formula & Manufacturing Processes
Title 17 - Part 5
Locum International Press.
Volume 17 - (Part 5)
Special Drug Development Series on
CD ROM
A Glimpse into the Future
This unique 10 part Series in the Handbook of Pharmaceutical Generic Development
provides in each of the series ten CDs consisting of ten
individual state-of-the-art real life commercial Master
Formulations together with the full manufacturing process. Title 17 Series
opens a window into the associations research and development product
pipeline. Allows researchers to view data and upgrade to the full Title
21 CMC as described in 'special features').
All key processing and control details highlighted. Title 21 CMC are authoritatively
written in a practical hands-on manner by pharma industry experts to the
level of both FDA and MCA/EU commercially approved manufacturing processes,
highlighting the wide variety of technical documentation and product development
expertise
All formula and processes are currently in production in the US or EU or both. Specifications and quantities are exact commercial amounts.
| 1. Etodoac ER 400 / 500 / 600mg Tablets |
| 2. Metformin 500 / 850mg Tablets |
| 3. Gabapentin ER 500/600 mg Tablets |
| 4. Carbamazepine 200mg Tablets |
| 5. Mesalamine DR 400mg Tablet |
| 6. Norfloxacin 400 mg Tablets |or| Sparfloxin 400 mg Tablets |
| 7. Azithromycin 200mg Suspension or Al+ Mg (Ultra-stable) Suspension |
| 8. Piperonal 2% Lotion | or | Furosemide 40mg Tablets |
| 9. Aciclovir Cream |
| 10.Cefaclor Oral Suspension 125;187;250;375 mg /5mL |
Complete
CD series is available as a ten part volume series of 10 CDs with
illustrated
diagrams, graphs, tables in b/w/color.
ISBN:
0793-6643
| Price - Title 17 - Part 5 |
USD$
|
| Members per CD (Ext Plans) |
1599.00
|
| Non-members |
1999.00
|
 |
 |
 |
 |
 |
 |
| Ready-To-Go Link
| Handbook Series | Journal
Index | Specialized Journals
| Title
17 Calandar |
